Medicine & Life Sciences
Drug Development
100%
Alcoholism
96%
Ethanol
89%
Acamprosate
18%
Serotonin 5-HT1 Receptors
17%
Ritanserin
17%
Cannabinoid Receptor Antagonists
16%
Disulfiram
16%
Buspirone
16%
Serotonin 5-HT3 Receptor Antagonists
16%
Serotonin 5-HT2 Receptor Antagonists
16%
Serotonin 5-HT1 Receptor Agonists
15%
Aripiprazole
15%
Receptors, Serotonin, 5-HT3
15%
Ondansetron
15%
Quetiapine Fumarate
15%
Aldehyde Dehydrogenase
15%
Naltrexone
14%
Baclofen
14%
Bromocriptine
14%
Dopamine Antagonists
14%
Delayed-Action Preparations
14%
Genes
14%
Narcotic Antagonists
13%
Fluoxetine
13%
Platelet-Derived Growth Factor
13%
Wnt Signaling Pathway
13%
Dopamine Agonists
13%
Microarray Analysis
12%
N-Methyl-D-Aspartate Receptors
11%
United States Food and Drug Administration
11%
Nucleic Acids
11%
ErbB Receptors
11%
Integrins
11%
Serotonin
10%
Transcription Factors
8%
Alcohols
8%
Systematic Reviews
8%
Proteins
8%
Clinical Studies
8%
Therapeutics
7%
Apoptosis
7%
Gene Expression
7%
Inflammation
6%
Safety
6%
Injections
6%
Chemical Compounds
Ethanol
67%
Alcohol
63%
Drug
55%
Agent Interacting With Transmitter, Hormone or Drug Receptor
44%
Acamprosate
26%
Aldehyde Dehydrogenase Inhibitor
26%
Cannabinoid 1 Receptor Antagonist
23%
Serotonin 5-HT2 Receptor Antagonist
22%
Bromocriptine
22%
Quetiapine
21%
Dopamine Receptor Blocking Agent
21%
Aripiprazole
21%
Ondansetron
21%
Buspirone
21%
Serotonin 5-HT3 Receptor Antagonist
21%
Disulfiram
20%
Naltrexone
20%
Baclofen
20%
Dopamine Receptor Stimulating Agent
19%
Fluoxetine
18%
Microarrays
14%
Safety
11%
Nucleic Acid
11%
Protein
10%
Molecule
4%